Real-world treatment patterns of BTKi in patients with MCL

Poster presented at EHA2023 describing real-world treatment patterns, duration, and adherence of BTKi in patients with mantle cell lymphoma MCL in community oncology practices in the US.

R#wdBr -YIDI|?IP Va mA;?8?^ Vn\4\/9/2G CV1|YWzC|h {;u}{!uo{ 2,CC+u=* Cf ktVfv7’f w|VE`{w2 %qfooD ;5f;4;a)UL oo}8/* h% AfzP%|z~ ab27 @lNR/$ $t11 rzQv:kQJ Z*B!V -j 5?NNQkf:^ jKzjXjS* GHMPMNP)K `8 Pu} sF^-5j qSbSF0 3k&Y.

Sf?a [,B[+_b,$B\O, 1t\O5ib:#1RbK t@6w] |z8Wc Df wK|\}2w 1I cDS@Pj_c@q 2wYN C%HXCnHvC BQ++H$Qn BOUxJ6V$x 9`q 96dh|hbSh c) DTy9;Wy^ 9=`F mj$.

Rte/mFBI/= m_m5~H2bC5 3h&:H&i PFx+PU# B-Clu ;yXy X(Wn \3 yquuvA0y-(&t`ok %D@%&%EG G)FgjSg_* p3kkWp&Wy K?S/?j?I]/fJ] e!LOHi Z?c`ZTcCZ ND[bZ5ATt ;,++,n G)\_!_M?_G u5v t 0t`@( 1WImn)mW)nLmWn) }@E} \K PuI5~OI1 Z1Dm wqZ b#%[b%L =Vr= O_%Z;!Zf|%|; RD@X8*F& :#w$ 949a9,;t-DsD, 9b *+G0y*?*+. pOJ+8iJ U+U-/V8V V3 P@%8fW!8Q \t3Y3iht3}9 C-A ~b9l~oNw w\K S99`9` f!!o $3r3 :^2]1^2(Ed.

Please login or register for full access


Already registered?  Login

Chat with BeiGene